FDA Office of Generic Drugs
Executive Summary
Deputy Director Gordon Johnston will depart from OGD Jan. 1 following acceptance of an associate position at Lachman Consultant Services. Johnston will be joining former OGD Deputy Director and Lachman VP Robert Pollock. OGD Labeling and Program Support Division Director Jerry Phillips begins a new post at the end of November as associate director for medication errors in the newly established Office of Post-marketing Drug Risk Assessment ("The Pink Sheet" Nov. 2, p. 6). Phillip's vacated position will be filled by Consumer Safety Officer Robert West. Division of Chemistry II Director Frank Holcombe will become OGD acting associate director for chemistry, and will be replaced by Florence Fong
You may also be interested in...
Former FDAer joins GPhA regulatory affairs
Former FDA Office of Generic Drugs Deputy Director Gordon Johnston is joining the Generic Pharmaceutical Association as VP-regulatory affairs. Johnston worked at FDA for 12 years, leaving OGD in January 1999 to join fellow former OGD Deputy Director Robert Pollack at Lachman Consultant Services (1"The Pink Sheet" Nov. 9, 1998, In Brief)...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011